The US Food and Drug Administration (FDA) has approved a new formulation of a drug that treats a type of blood cancer.

The US Food and Drug Administration (FDA) has approved a new medication to treat multiple myeloma.

The US Food and Drug Administration (FDA) approved a new formula of melphalan under the brand name Evomela to treat patients with multiple myeloma.

Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.

Before November, there were seven FDA-approved medications to treat multiple myeloma. Now that November is over, there are 10.

Another treatment for multiple myeloma just got an OK from the FDA.

A new FDA approval could give another option to multiple myeloma patients who haven't had luck with past treatments. {C}

For multiple myeloma patients who haven't responded to past treatments, a newly approved medication could provide hope.

When it comes to treating multiple myeloma, three medications may be better than two.

Multiple myeloma is a cancer that develops in the bone marrow and is considered by many to be incurable. An engineered measles virus, however, may change that.